Patients with multiple sclerosis (MS) are more likely to experience health problems before they receive their formal diagnosis, as well as to experience serious non-MS-related complications after diagnosis, a study reveals.
The findings were reported in the study “Increased risk of comorbidities in patients before as well as after multiple sclerosis (MS) diagnosis: a study in the UK Clinical Practice Research Datalink (CPRD),” that was presented at the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), being held Oct. 10-12, in Berlin, Germany. The data were presented by Neil Minton, of the biopharmaceutical corporation Celgene, San Diego, California.
There is little information on the health of patients with MS in the short period before and after their diagnosis.
Researchers at Celgene, in collaboration with others from the Boston Collaborative Drug Surveillance Program at Boston University School of Public Health, reviewed the clinical records of 6,932 MS patients, and